While further investigation for PAPSS2 is required, depletion of the PAPSS1 isoform sensitized NSCLC to cisplatin suggesting that targeting sulfation reactions might improve activity of cisplatin or other DNA damaging agents (83). The gene discussed is PAPSS2; the disease is non-small cell lung carcinoma.